News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
457,459 Results
Type
Article (32859)
Company Profile (88)
Press Release (424508)
Multimedia
Podcasts (63)
Webinars (10)
Section
Business (119702)
Career Advice (813)
Deals (18942)
Drug Delivery (77)
Drug Development (56812)
Employer Resources (70)
FDA (13391)
Job Trends (10173)
News (214041)
Policy (22043)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (2)
Academia (2210)
Accelerated approval (20)
Adcomms (19)
Allergies (121)
Alliances (31393)
ALS (115)
Alzheimer's disease (1174)
Antibody-drug conjugate (ADC) (192)
Approvals (13650)
Artificial intelligence (350)
Autoimmune disease (101)
Automation (14)
Bankruptcy (160)
Best Places to Work (8115)
BIOSECURE Act (6)
Biosimilars (92)
Biotechnology (57)
Bladder cancer (134)
Brain cancer (42)
Breast cancer (506)
Cancer (3698)
Cardiovascular disease (307)
Career advice (685)
Career pathing (19)
CAR-T (190)
CDC (41)
Celiac Disease (2)
Cell therapy (492)
Cervical cancer (30)
Clinical research (50421)
Collaboration (1046)
Compensation (290)
Complete response letters (33)
COVID-19 (2004)
CRISPR (47)
C-suite (546)
Cystic fibrosis (86)
Data (4830)
Decentralized trials (2)
Denatured (27)
Depression (97)
Diabetes (354)
Diagnostics (4446)
Digital health (36)
Diversity (12)
Diversity, equity & inclusion (21)
Drug discovery (130)
Drug pricing (142)
Drug shortages (23)
Duchenne muscular dystrophy (151)
Earnings (43516)
Editorial (41)
Employer branding (9)
Employer resources (66)
Events (67536)
Executive appointments (655)
FDA (15866)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (8)
Frontotemporal dementia (15)
Funding (883)
Gene editing (104)
Generative AI (25)
Gene therapy (378)
GLP-1 (633)
Government (3739)
Grass and pollen (4)
Guidances (256)
Healthcare (14454)
HIV (45)
Huntington's disease (25)
IgA nephropathy (55)
Immunology and inflammation (113)
Immuno-oncology (39)
Indications (71)
Infectious disease (2189)
Inflammatory bowel disease (125)
Inflation Reduction Act (13)
Influenza (74)
Intellectual property (131)
Interviews (94)
IPO (7965)
IRA (39)
Job creations (2330)
Job search strategy (629)
JPM (25)
Kidney cancer (12)
Labor market (46)
Layoffs (260)
Leadership (8)
Legal (4181)
Liver cancer (75)
Longevity (8)
Lung cancer (541)
Lymphoma (301)
Machine learning (18)
Management (21)
Manufacturing (415)
MASH (122)
Medical device (13672)
Medtech (13720)
Mergers & acquisitions (11564)
Metabolic disorders (863)
Multiple sclerosis (114)
NASH (13)
Neurodegenerative disease (197)
Neuropsychiatric disorders (49)
Neuroscience (2005)
NextGen: Class of 2026 (4927)
Non-profit (3681)
Now hiring (37)
Obesity (367)
Opinion (122)
Ovarian cancer (144)
Pain (159)
Pancreatic cancer (168)
Parkinson's disease (187)
Partnered (20)
Patents (264)
Patient recruitment (407)
Peanut (45)
People (39429)
Pharmaceutical (22)
Pharmacy benefit managers (17)
Phase 1 (14969)
Phase 2 (22127)
Phase 3 (17263)
Pipeline (3546)
Policy (209)
Postmarket research (1852)
Preclinical (4894)
Press Release (37)
Prostate cancer (199)
Psychedelics (28)
Radiopharmaceuticals (207)
Rare diseases (565)
Real estate (4253)
Recruiting (28)
Regulatory (17512)
Reports (22)
Research institute (2088)
Resumes & cover letters (114)
Rett syndrome (18)
RNA editing (5)
RSV (57)
Schizophrenia (121)
Series A (130)
Series B (105)
Service/supplier (4)
Sickle cell disease (73)
Special edition (9)
Spinal muscular atrophy (115)
Sponsored (24)
Startups (2461)
Stomach cancer (13)
Supply chain (77)
Tariffs (44)
The Weekly (35)
Vaccines (721)
Venture capital (38)
Weight loss (247)
Women's health (66)
Worklife (6)
Date
Today (73)
Last 7 days (443)
Last 30 days (1388)
Last 365 days (18973)
2026 (1884)
2025 (19207)
2024 (22895)
2023 (26264)
2022 (35046)
2021 (37796)
2020 (36971)
2019 (33500)
2018 (25641)
2017 (21574)
2016 (21126)
2015 (24576)
2014 (18482)
2013 (15373)
2012 (16770)
2011 (17000)
2010 (15236)
Location
Africa (449)
Alabama (41)
Alaska (4)
Arizona (201)
Arkansas (11)
Asia (28878)
Australia (4393)
California (6625)
Canada (2084)
China (889)
Colorado (347)
Connecticut (317)
Delaware (277)
Europe (56840)
Florida (1112)
Georgia (272)
Hawaii (1)
Idaho (41)
Illinois (647)
India (43)
Indiana (413)
Iowa (13)
Japan (343)
Kansas (95)
Kentucky (28)
Louisiana (20)
Maine (31)
Maryland (977)
Massachusetts (4526)
Michigan (193)
Minnesota (480)
Mississippi (6)
Missouri (82)
Montana (30)
Nebraska (22)
Nevada (74)
New Hampshire (78)
New Jersey (2133)
New Mexico (15)
New York (1936)
North Carolina (923)
North Dakota (4)
Northern California (3125)
Ohio (251)
Oklahoma (13)
Oregon (33)
Pennsylvania (1576)
Puerto Rico (19)
Rhode Island (37)
South America (643)
South Carolina (59)
Southern California (2651)
Tennessee (148)
Texas (1196)
United States (25356)
Utah (228)
Vermont (1)
Virginia (167)
Washington D.C. (60)
Washington State (484)
West Virginia (4)
Wisconsin (80)
Wyoming (1)
457,459 Results for "summit medical center".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Regulatory
Summit’s Potential Keytruda Rival Gets November FDA Decision Date
The FDA is currently reviewing Summit’s PD-1/VEGF bispecific as part of a chemotherapy combo for the treatment of locally advanced or metastatic non-squamous non-small cell lung cancer.
January 30, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Cogent Biosciences Announces Multiple SUMMIT Posters at the 2026 AAAAI Annual Meeting
February 10, 2026
·
3 min read
Lung cancer
Summit Eyes 2025 FDA Application for Ivonescimab Despite Overall Survival Miss
In May, Summit released early data from the Phase III HARMONi study showing that while the PD-1/VEGF inhibitor resulted in significant progression-free survival improvements, it fell short of the overall survival bar.
October 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Inventiva to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
February 5, 2026
·
1 min read
Press Releases
Vaxcyte to Present at the Guggenheim Emerging Outlook: Biotech Summit
February 6, 2026
·
2 min read
Press Releases
DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit
February 10, 2026
·
2 min read
Press Releases
Ascentage Pharma to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
February 9, 2026
·
5 min read
Press Releases
UroGen Pharma to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit
February 4, 2026
·
1 min read
Press Releases
Rhythm Pharmaceuticals Announces Participation in Upcoming Guggenheim Biotech Summit
February 5, 2026
·
7 min read
Press Releases
Rezolute to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
February 4, 2026
·
1 min read
1 of 45,746
Next
